002317 眾生藥業
按盤價 
11.600 +0.170 (+1.487%)
11.600 +0.170 (+1.487%) | 2024/03 - 三個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 1.170 | 6.534 | 8.973 | 7.932 | -11.240 |
| 總資產報酬率 ROA (%) | 0.809 | 4.304 | 6.032 | 5.737 | -8.298 |
| 投入資產回報率 ROIC (%) | 0.902 | 4.798 | 6.656 | 6.283 | -9.917 | 邊際利潤分析 |
| 銷售毛利率 (%) | 56.490 | 58.596 | 64.857 | 66.796 | 65.337 |
| 營業利潤率 (%) | 9.245 | 11.443 | 13.985 | 12.872 | -17.100 |
| 息稅前利潤/營業總收入 (%) | 9.569 | 11.509 | 15.901 | 14.731 | -17.722 |
| 淨利潤/營業總收入 (%) | 7.598 | 9.573 | 11.784 | 11.308 | -22.915 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 129.277 | 111.068 | 88.538 | 105.659 | -71.284 |
| 價值變動淨收益/利潤總額(%) | -31.005 | -14.702 | 7.290 | -14.883 | -69.011 |
| 營業外收支淨額/利潤總額(%) | -0.266 | -5.314 | -1.618 | -1.029 | 6.105 | 償債能力分析 |
| 流動比率 (X) | 4.318 | 3.901 | 2.918 | 5.096 | 3.823 |
| 速動比率 (X) | 3.724 | 3.388 | 2.484 | 4.234 | 3.330 |
| 資產負債率 (%) | 26.459 | 29.927 | 33.917 | 27.822 | 24.070 |
| 帶息債務/全部投入資本 (%) | 5.975 | 10.781 | 17.491 | 11.050 | -- |
| 股東權益/帶息債務 (%) | 1,326.538 | 696.408 | 409.311 | 698.178 | 501.764 |
| 股東權益/負債合計 (%) | 267.789 | 225.383 | 189.029 | 254.843 | 306.629 |
| 利息保障倍數 (X) | 27.508 | 17.900 | 7.436 | 7.400 | -36.152 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 67.959 | 67.718 | 66.894 | 66.378 | 0.000 |
| 存貨周轉天數 (天) | 163.075 | 166.773 | 178.616 | 191.041 | 0.000 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 01/07/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
